Form 4: PMV Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Deepika Jalota, Chief Development Officer of PMV Pharmaceuticals, sold shares of common stock to cover tax obligations related to vesting of restricted stock units.
Summary
- Deepika Jalota, Chief Development Officer of PMV Pharmaceuticals, sold 7,218 shares of common stock on September 11, 2024.
- The shares were sold at a price of $1.5036 per share.
- The sale was executed to cover the reporting person's tax obligations in connection with the vesting of restricted stock units (RSUs).
- Following the transaction, Jalota still beneficially owns 118,283 shares of PMV Pharmaceuticals.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations). It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction is a routine financial activity and doesn't necessarily indicate a change in the executive's confidence in the company.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 09/11/2024 | Date of the transaction (sale of shares) |
| 09/12/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.